4.7 Review

Quality and Equitable Health Care Gaps for Women Attributions to Sex Differences in Cardiovascular Medicine

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 70, Issue 3, Pages 373-388

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2017.05.051

Keywords

disparities; health care quality; sex differences

Funding

  1. Gatorade Trust through funds the University of Florida, Department of Medicine
  2. NIH NCATS-University of Florida Clinical and Translational Science [UL1TR001427]
  3. PCORnet-OneFlorida Clinical Research Consortium [CDRN-1501-26692]
  4. Adelphi Values
  5. AMGEN
  6. AstraZeneca
  7. Athersys
  8. Boehringer Ingelheim
  9. Brigham and Women's Hospital
  10. Capricor Inc.
  11. Cytori Therapeutics
  12. Daiichi-Sankyo
  13. Duke University
  14. Gilead Sciences, Inc.
  15. inVentive Health Clinical LLC
  16. Merck Co.
  17. National Institutes of Health/National Heart, Lung, and Blood Institute
  18. Minocycline HTN
  19. Microbiota HTN
  20. Microbiota
  21. Relypsa
  22. Sanofi
  23. Boehringer Ingleheim
  24. St. Jude Medical
  25. National Institute on Minority Health and Health Disparities of the National Institutes of Health [U54MD008149, 8 U54 MD007588]
  26. National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]

Ask authors/readers for more resources

The present review synthesizes evidence and discusses issues related to health care quality and equity for women, including minority population subgroups. The principle of sameness or women and men receiving equitable, high-quality care is a near-term target, but optimal population health cannot be achieved without consideration of the unique, gendered structural determinants of health and the development of unique care pathways optimized for women. The aim of this review is to promote enhanced awareness, develop critical thinking in sex and gender science, and identify strategic pathways to improve the cardiovascular health of women. Delineation of the components of high-quality health care, including a women-specific research agenda, remains a vital part of strategic planning to improve the lives of women at risk for or living with cardiovascular disease. (C) 2017 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available